Published in
American Society of Hematology, Blood, 10(126), p. 1203-1213, 2015
DOI: 10.1182/blood-2015-04-640532
Links
- American Society of Hematology | PDF
- ORCID
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
Tools
The antigenic landscape of multiple myeloma: Mass spectrometry (re)defines targets for T-cell-based immunotherapy
Journal article published in 2015 by
Simon Walz 
,
Juliane S. Stickel,
Daniel Johannes Kowalewski,
Heiko Schuster,
Katja Weisel,
Linus Backert,
Stefan Kahn,
Annika Nelde,
Tatjana Stroh,
Martin Handel,
Oliver Kohlbacher,
Lothar Kanz,
Helmut Rainer Salih,
Hans-Georg Rammensee,
S. Stevanovi
and other authors.
,
Juliane S. Stickel,
Daniel Johannes Kowalewski,
Heiko Schuster,
Katja Weisel,
Linus Backert,
Stefan Kahn,
Annika Nelde,
Tatjana Stroh,
Martin Handel,
Oliver Kohlbacher,
Lothar Kanz,
Helmut Rainer Salih,
Hans-Georg Rammensee,
S. Stevanovi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Direct analysis of the HLA-presented peptidome identifies a distinct antigenic signature in MM. T-cell responses for these antigens are detectable exclusively in MM patients and can be induced in vitro in response-naive patients.